Mitigating Biotin Interference in the Clinical Laboratory
Mitigating biotin interference on immunoassays is a critical factor to ensure appropriate diagnosis and treatment.
Read MorePosted by Chris Wolski | Apr 23, 2025 | Immunoassay |
Mitigating biotin interference on immunoassays is a critical factor to ensure appropriate diagnosis and treatment.
Read MorePosted by Chris Wolski | Apr 22, 2025 | Molecular Diagnostics |
bioMérieux has launched the WATCHFIRE R Panel, a rapid wastewater-based molecular test that detects 22 respiratory pathogens.
Read MorePosted by Chris Wolski | Apr 14, 2025 | Emerging & Zoonotic Diseases |
The Oropouche virus, once thought rare, is now recognized as widely underdiagnosed in Latin America, and needs more research.
Read MorePosted by Chris Wolski | Apr 1, 2025 | Sexually Transmitted Diseases |
A new self-testing microchip for HIV detection aims to provide an affordable, rapid, and accessible way to detect early HIV infections.
Read MorePosted by Chris Wolski | Mar 24, 2025 | Covid 19 |
Industry experts predict clinical diagnostics will continue evolving in the wake of COVID with automation, AI, and decentralized testing.
Read More